These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
449 related articles for article (PubMed ID: 9519744)
1. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM. Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744 [TBL] [Abstract][Full Text] [Related]
2. Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects. Kruszynska YT; Mulford MI; Baloga J; Yu JG; Olefsky JM Diabetes; 1998 Jul; 47(7):1107-13. PubMed ID: 9648835 [TBL] [Abstract][Full Text] [Related]
3. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients. Vestergaard H; Bjørbaek C; Hansen T; Larsen FS; Granner DK; Pedersen O J Clin Invest; 1995 Dec; 96(6):2639-45. PubMed ID: 8675629 [TBL] [Abstract][Full Text] [Related]
4. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680 [TBL] [Abstract][Full Text] [Related]
5. Exercise increases hexokinase II mRNA, but not activity in obesity and type 2 diabetes. Cusi KJ; Pratipanawatr T; Koval J; Printz R; Ardehali H; Granner DK; Defronzo RA; Mandarino LJ Metabolism; 2001 May; 50(5):602-6. PubMed ID: 11319725 [TBL] [Abstract][Full Text] [Related]
6. Regulation of hexokinase II expression in human skeletal muscle in vivo. Vogt C; Ardehali H; Iozzo P; Yki-Järvinen H; Koval J; Maezono K; Pendergrass M; Printz R; Granner D; DeFronzo R; Mandarino L Metabolism; 2000 Jun; 49(6):814-8. PubMed ID: 10877213 [TBL] [Abstract][Full Text] [Related]
7. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism. Vestergaard H Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651 [TBL] [Abstract][Full Text] [Related]
8. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients. Kelley DE; Mokan M; Mandarino LJ Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246 [TBL] [Abstract][Full Text] [Related]
9. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Mandarino LJ; Consoli A; Jain A; Kelley DE Am J Physiol; 1996 Mar; 270(3 Pt 1):E463-70. PubMed ID: 8638694 [TBL] [Abstract][Full Text] [Related]
10. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects. Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019 [TBL] [Abstract][Full Text] [Related]
11. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training. Dela F; Larsen JJ; Mikines KJ; Ploug T; Petersen LN; Galbo H Diabetes; 1995 Sep; 44(9):1010-20. PubMed ID: 7657022 [TBL] [Abstract][Full Text] [Related]
12. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Laakso M; Edelman SV; Brechtel G; Baron AD Diabetes; 1992 Sep; 41(9):1076-83. PubMed ID: 1499861 [TBL] [Abstract][Full Text] [Related]